Concepedia

Author

Alain Thibault

National Cancer Institute

Also Known As

A Thibault, A. THIBAULT, A. Thibault, Alain A. Thibault, Alain Thibault, Thibault, Alain

81

Publications

3.1K

Citations

26

H-Index

57

Concepts

All Affiliations

National Cancer InstituteNational Institutes of HealthAblynx (Belgium)University of RochesterInstitut Jules Bordet
AT

About

Alain Thibault is an author at National Cancer Institute specializing in medicine, oncology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

15

995

2

Health Sciences

2

2

81

3

Biochemistry

2

2

88

4

Engineering

1

1

11

5

Allergy

1

1

100

Alain Thibault

×

36

Publications

3K

Citations

26

H-Index

YearCitations

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann,

Blood

2001

445

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Alain Thibault, Dvorit Samid, A Tompkins,

PubMed

1996

361

Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies

Jörge E. Cortes, Maher Albitar, Deborah A. Thomas,

Blood

2003

209

A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.

Alain Thibault, Michael R. Cooper, William D. Figg,

PubMed

1994

157

Phase II Study of R115777, a Farnesyl Transferase Inhibitor, in Myelodysplastic Syndrome

Razelle Kurzrock, Maher Albitar, Jörge E. Cortes,

Journal of Clinical Oncology

2004

146

Surprising Activity of Flutamide Withdrawal, When Combined With Aminoglutethimide, in Treatment of "Hormone-Refractory" Prostate Cancer

Oliver Sartor, Michael R. Cooper, M. Weinberger,

JNCI Journal of the National Cancer Institute

1994

138

A Phase II Study of 5-AZA-2'Deoxycytidine (Decitabine) in Hormone Independent Metastatic (D2) Prostate Cancer

Alain Thibault, William D. Figg, Raymond C. Bergan,

Tumori Journal

1998

136

Phase I study of phenylacetate administered twice daily to patients with cancer

Alain Thibault, Dvorit Samid, Michael R. Cooper,

Cancer

1995

129

Risk Factors for the Development of <i>Clostridium difficile</i> -Associated Diarrhea During a Hospital Outbreak

Alain Thibault, Mark A. Miller, Christina Gaese

Infection Control and Hospital Epidemiology

1991

118

Lipid Metabolism as a Target for Brain Cancer Therapy: Synergistic Activity of Lovastatin and Sodium Phenylacetate Against Human Glioma Cells

Premakala Prasanna, Alain Thibault, Lei Liu,

Journal of Neurochemistry

1996

113

Page 1